Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

Similar articles for PubMed (Select 24033753)

1.

Clinical experience of subcutaneous and transvenous implantable cardioverter defibrillators in children and teenagers.

Pettit SJ, McLean A, Colquhoun I, Connelly D, McLeod K.

Pacing Clin Electrophysiol. 2013 Dec;36(12):1532-8. doi: 10.1111/pace.12233. Epub 2013 Sep 13.

PMID:
24033753
2.

A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population.

Stephenson EA, Batra AS, Knilans TK, Gow RM, Gradaus R, Balaji S, Dubin AM, Rhee EK, Ro PS, Thøgersen AM, Cecchin F, Triedman JK, Walsh EP, Berul CI.

J Cardiovasc Electrophysiol. 2006 Jan;17(1):41-6.

PMID:
16426398
3.

Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study.

Köbe J, Reinke F, Meyer C, Shin DI, Martens E, Kääb S, Löher A, Amler S, Lichtenberg A, Winter J, Eckardt L.

Heart Rhythm. 2013 Jan;10(1):29-36. doi: 10.1016/j.hrthm.2012.09.126. Epub 2012 Sep 29.

PMID:
23032867
4.

Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry.

Lambiase PD, Barr C, Theuns DA, Knops R, Neuzil P, Johansen JB, Hood M, Pedersen S, Kääb S, Murgatroyd F, Reeve HL, Carter N, Boersma L; EFFORTLESS Investigators.

Eur Heart J. 2014 Jul 1;35(25):1657-65. doi: 10.1093/eurheartj/ehu112. Epub 2014 Mar 26.

5.
6.

System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverter-defibrillators in pediatric and congenital heart disease patients.

Radbill AE, Triedman JK, Berul CI, Fynn-Thompson F, Atallah J, Alexander ME, Walsh EP, Cecchin F.

Heart Rhythm. 2010;7(2):193-8. doi: 10.1016/j.hrthm.2009.10.014. Epub 2009 Oct 14.

PMID:
20022820
7.

Transvenous defibrillator systems implanted by electrophysiologists in the catheterization laboratory.

Manolis AS, Vassilikos V, Maounis T, Chiladakis J, Cokkinos DV.

Clin Cardiol. 1997 Feb;20(2):117-24.

PMID:
9034640
8.
9.

The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort.

Olde Nordkamp LR, Dabiri Abkenari L, Boersma LV, Maass AH, de Groot JR, van Oostrom AJ, Theuns DA, Jordaens LJ, Wilde AA, Knops RE.

J Am Coll Cardiol. 2012 Nov 6;60(19):1933-9. doi: 10.1016/j.jacc.2012.06.053. Epub 2012 Oct 10.

10.

High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.

Korte T, Köditz H, Niehaus M, Paul T, Tebbenjohanns J.

Pacing Clin Electrophysiol. 2004 Jul;27(7):924-32.

PMID:
15271011
11.

Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy.

Olde Nordkamp LR, Knops RE, Bardy GH, Blaauw Y, Boersma LV, Bos JS, Delnoy PP, van Dessel PF, Driessen AH, de Groot JR, Herrman JP, Jordaens LJ, Kooiman KM, Maass AH, Meine M, Mizusawa Y, Molhoek SG, van Opstal J, Tijssen JG, Wilde AA.

Am Heart J. 2012 May;163(5):753-760.e2. doi: 10.1016/j.ahj.2012.02.012.

12.

Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients.

Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK, Cannon BC, Alexander ME, Triedman JK, Walsh EP, Friedman RA.

J Am Coll Cardiol. 2008 Apr 29;51(17):1685-91. doi: 10.1016/j.jacc.2008.01.033.

13.

Survival of transvenous ICD leads in young patients.

Bonney WJ, Spotnitz HM, Liberman L, Silver ES, Ceresnak SR, Hordof AJ, Pass RH.

Pacing Clin Electrophysiol. 2010 Feb;33(2):186-91. doi: 10.1111/j.1540-8159.2009.02600.x. Epub 2009 Dec 11.

PMID:
20002886
14.

Implantable transvenous cardioverter-defibrillators.

Bardy GH, Hofer B, Johnson G, Kudenchuk PJ, Poole JE, Dolack GL, Gleva M, Mitchell R, Kelso D.

Circulation. 1993 Apr;87(4):1152-68.

PMID:
8462144
15.

Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics.

Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI.

J Cardiovasc Electrophysiol. 2004 Jan;15(1):72-6.

PMID:
15028076
16.

First clinical experience with the new four-pole standard connector for high-voltage ICD leads. Early results of a multicenter comparison with conventional implant outcomes.

Forleo GB, Di Biase L, Mantica M, Panattoni G, Santamaria M, Parisi Q, Sergi D, Papavasileiou LP, Santini L, Tondo C, Natale A, Romeo F.

J Interv Card Electrophysiol. 2013 Oct;38(1):11-8. doi: 10.1007/s10840-013-9814-6. Epub 2013 Jul 3.

PMID:
23820882
17.

Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.

Griksaitis MJ, Rosengarten JA, Gnanapragasam JP, Haw MP, Morgan JM.

Europace. 2013 Apr;15(4):523-30. doi: 10.1093/europace/eus388. Epub 2013 Jan 20.

18.

Epicardial and pleural lead ICD systems in children and adolescents maintain functionality over 5 years.

Tomaske M, Prêtre R, Rahn M, Bauersfeld U.

Europace. 2008 Oct;10(10):1152-6. doi: 10.1093/europace/eun214. Epub 2008 Aug 13.

19.

Implantable cardioverter defibrillator-related complications in the pediatric population.

Shah MJ.

Pacing Clin Electrophysiol. 2009 Jul;32 Suppl 2:S71-4. doi: 10.1111/j.1540-8159.2009.02389.x. Review.

PMID:
19602168
20.

Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator.

Knops RE, Olde Nordkamp LR, de Groot JR, Wilde AA.

Heart Rhythm. 2013 Aug;10(8):1240-3. doi: 10.1016/j.hrthm.2013.05.016. Epub 2013 May 21.

PMID:
23707489
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk